Set Your Sights On Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX)’S Upside Potential
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on Thursday at a closing price of $7.93, with 2.04 million shares of worth about $16.17 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 36.25% during that period and on August 22, 2024 the price saw a […]
Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) – Not A Clear Buying Opportunity?
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on Wednesday at a closing price of $7.44, with 3.93 million shares of worth about $29.26 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 35.03% during that period and on August 07, 2024 the price saw a […]
Following The Money: Institution’s Growing Stake In Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX)
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on Thursday at a closing price of $7.55, with 3.02 million shares of worth about $22.81 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 39.81% during that period and on July 25, 2024 the price saw a […]
Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX): To Buy Or Not To Buy, That Is The Question
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on Wednesday at a closing price of $7.27, with 3.7 million shares of worth about $26.87 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 19.38% during that period and on July 17, 2024 the price saw a […]
Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX): Analyst View Points To Future Growth
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on Thursday at a closing price of $7.04, with 4.15 million shares of worth about $29.2 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -5.38% during that period and on July 11, 2024 the price saw a […]
Investors Should Take Note Of Biocryst Pharmaceuticals Inc. (BCRX)
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on Wednesday at a closing price of $5.57, with 4.17 million shares of worth about $23.21 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.74% during that period and on Wednesday the price saw a gain of […]
Stick With Biocryst Pharmaceuticals Inc. (BCRX). The Bull Are Alive And Well
The Vanguard Group, Inc. recently announced the acquisition of new stake in Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX). The institutional investor has increased its shareholding in the Healthcare company by 2.08% to 14.9 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 7.28% valued currently at $87.61 million. In addition, […]
Is Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) Proving The Doubters Wrong?
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on 01/04/24 at a closing price of $6.46, with 3.96 million shares of worth about $25.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -7.18% during that period and on Thursday the price saw a gain of […]
Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) Stock In Prove Me State
The Vanguard Group, Inc. has recently announced that it has increased stake in Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) by 2.08%. After grabbing 14.9 million shares, the institutional investor is now in possession of 0.3 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.28% having worth around $87.61 million. […]
These Numbers Could Change Investor Views For Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX). The institutional investor has increased its shareholding in the Healthcare company by 2.08% to 14.9 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 7.28% valued currently at $87.61 million. In addition, […]
